CD28 and lung cancer: As expected, testing of tumor sphering cells, generated from the MHC+ lung cancer cell (A549) [16] clonal formation, found that majority of tumor sphering cells were not induced immune killing and maintained nearly equal cell viability after supplementing with CD28 costimulatory signals compared to controls (Fig.S1a-b).